General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Cash Flow From Operating Activities        
Net loss $ (8,081) $ (7,175) $ (8,775) $ (7,029)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation expense 237 119 185 78
Amortization of right of use asset 441 331 460 415
Amortization of intangible assets 4 3 5 5
Non-cash interest income (88) (88) (299)
Stock based compensation 280 220 309 45
Change in fair value of derivative liabilities (208) (225) (696) (2,111)
Forgiveness of PPP loan (391)    
Offering costs     325
Loss (gain) on disposal of property and equipment 1 (144) (144)
Non-cash other income – forgiveness of loans     (905)
Bad debt expense (2)    
Changes in operating assets and liabilities:        
Trade accounts receivable 66 (140) (61) 94
Prepaid expenses and other current assets (346) (177) (149) (91)
Inventories (151) (203) (110) 153
Accounts payable and accrued liabilities 25 417 264 (350)
Other liabilities (32) (26)
Payments on operating lease liability (414) (294) (401) (347)
Net cash used in operating activities (8,180) (7,747) (10,132) (9,112)
Cash Flows From Investing Activities        
Purchase of property and equipment (1,109) (3,210) (3,739) (360)
Proceeds from notes receivable, net of imputed interest 1,944 1,944 2,111
Cash acquired in acquisition (see Note 2) 303    
Proceeds from sale of property and equipment 1 144 144
Net cash used in investing activities (805) (1,122) (1,651) 1,751
Cash Flows From Financing Activities        
Proceeds from issuance of warrant derivative liabilities     6,328
Proceeds from issuance of common stock, net of fees     19,995
Proceeds from issuance of preferred stock, net of fees     3,112
Proceeds from issuance of common stock in connection with exercise of warrants 196 196 1,111
Payments on debt (509) (5) (27)
Proceeds from issuance of debt 510 509 406
Net cash provided by (used in) financing activities (509) 701 705 30,925
Net decrease in cash and cash equivalents (9,494) (8,168) (11,078) 23,564
Cash and cash equivalents at beginning of period 14,273 25,351 25,351 1,787
Cash and cash equivalents at end of period 4,779 17,183 14,273 25,351
Noncash Investing and Financing Activities        
Right-of-Use Assets and assumption of operating lease liability 27 918 918
Extinguishment of derivative liabilities through exercise of warrants 195 195 3,199
Change in par value due to conversion of preferred stock to common stock     65
Issuance of Common Stock for the Cashless Exercise of Warrants     35
Acquisition of subsidiary through assumption of debt (see Note 2) 22    
Supplemental Cash Flow Information        
Cash paid for interest $ 32 $ 2